SCHEMBL26357305

SCHEMBL26357305

CC(=O)N(O)C/C=C/c1cccc(Cc2ccccc2)c1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.67
▸ PTGS1 P23219 2/20 0.67
▸ PTGS2 P35354 2/20 0.67
▸ ALOX5AP P20292 1/20 0.67
▸ EPOR P19235 4/20 0.43
▸ LTB4R Q15722 1/20 0.41
▸ LTB4R2 Q9NPC1 1/20 0.41
▸ CYP4F2 P78329 1/20 0.40
▸ CYP4A11 Q02928 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ AKR1B10 O60218 1/20 0.38
▸ AKR1B1 P15121 1/20 0.38
▸ MTNR1A P48039 1/20 0.37
▸ MTNR1B P49286 1/20 0.37
▸ PAM P19021 1/20 0.37
▸ ELANE P08246 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3899072 0.80 ALOX5 (1.00) ALOX5PTGS1PTGS2ALOX5APEPOR
SCHEMBL3903195 0.80 ALOX5 (1.00) ALOX5PTGS1PTGS2ALOX5APEPOR
SCHEMBL29808733 0.80 ALOX5 (1.00) ALOX5PTGS1PTGS2ALOX5APEPOR
SCHEMBL28357772 0.75 KDM4E (0.63) ALOX5PTGS2LTB4RLTB4R2LMNA
SCHEMBL28357770 0.75 KDM4E (0.63) ALOX5PTGS2LTB4RLTB4R2LMNA
SCHEMBL9707281 0.74 ALOX5 (0.64) ALOX5PTGS1PTGS2ALOX5AP
SCHEMBL27965115 0.71 PAM (0.52) ALOX5PTGS1PTGS2ALOX5APLMNA
SCHEMBL27965116 0.71 PAM (0.52) ALOX5PTGS1PTGS2ALOX5APLMNA
SCHEMBL8987031 0.71 TBXAS1 (0.56) PTGS1LTB4RLTB4R2KDM4EALDH1A1
SCHEMBL8987027 0.71 TBXAS1 (0.56) PTGS1LTB4RLTB4R2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773111-B1 Selective 5-LO inhibitors for the treatment of bronchial asthma King Faisal University (SA) 2023-10-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773111-B1 Selective 5-LO inhibitors for the treatment of bronchial asthma ALOX5, LTC4S, NOX5 ALOX5 1/4885PTGS1 150/4885PTGS2 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback